Question

the second generation NSAID( COX-2 Inhibitos) is very low cost true or false?

Answer 1

Second generation are low cost and cost effective ,

according to a paper published in 2008 ,Cost-effectiveness analysis for pain treatment in patients with osteoarthritis .

showed that the best cost-effectiveness results [lowest cost-effectiveness ratio $17.5 pesos/patient ($1.75 USD)] was celecoxib. According to the one-way sensitivity analysis, celecoxib would need to markedly decrease its effectiveness in order for it to not be the optimal treatment option. In the probabilistic analysis, both in the construction of the acceptability curves and in the estimation of net economic benefits, the most cost-effective option was celecoxib.